跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BPO FACIAL GEL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BPO FACIAL GEL
Authorized
STANDARD
BPO FACIAL GEL
alumier europe ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b14f7bce0ebf370d
Company
alumier europe ltd
Type
Standard
Approval Details
Approval Id
b14f7bce0ebf370d
Drug Approval Canada Name
BPO FACIAL GEL
Product Name
BPO FACIAL GEL
Status
Marketed
Status Date
2022-11-28
Original Market Date
2022-11-28
Din
02517043
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:28.00
Atc Original
D10AE01 BENZOYL PEROXIDE
Atc Name
d 10 ae 01
Aig Number
0107205004
Company Name
alumier europe ltd
Company Address
Vision Exchange Building, Territorials Street, Zone 1, Central Business District, Birkirkara, --, Malta, CBD1070
Active Ingredients
BENZOYL PEROXIDE
2.5 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b14f7bce0ebf370d
Type
Standard
Back to Health Canada Approvals